TNFRSF10B and colorectal carcinoma: Using immunohistochemistry, we have studied the expression of TRAIL and its receptors in Saudi CRC; incidence of TRAIL R1, TRAIL-R2 and TRAIL expression was 85.5%, 59.4% and 31.5% respectively.